Skip to main content
. 2021 Jul 19;12:701006. doi: 10.3389/fimmu.2021.701006

Figure 4.

Figure 4

Tumor immunotherapy strategies based on B7-H3. (A) Targeting B7-H3 with blocking mAbs; (B) Targeting B7-H3 through ADCC; (C) Targeting B7-H3 through ADC therapies; (D) Targeting B7-H3 with CD3-engaging BsAbs; (E) BiKEs and TriKEs; (F) Targeting B7-H3 with small-molecule inhibitors; (G) Targeting B7-H3 with CAR T cells and CAR-NK cells; (H) Synergistic options with anti B7-H3 therapies.